Table 2:
Incidence of AN according to baseline eGFR
| eGFR/Time Point | Cases (%) | Controls (%) | Pa |
|---|---|---|---|
| All Patients | |||
| 24 Hours (499 cases and 288 controls) | 8 (2) | 15 (5) | .007 |
| 48 Hours (428 cases and 232 controls) | 14 (3) | 18 (8) | .01 |
| 72 Hours (382 cases and 206 controls) | 19 (5) | 14 (7) | .4 |
| Cumulative incidence (575 cases and 343 controls) | 28 (5) | 35 (10) | .003 |
| eGFR > 60 mL/min/1.73 m2 | |||
| 24 Hours (376 cases and 164 controls) | 7 (2) | 12 (7) | .004 |
| 48 Hours (320 cases and 133 controls) | 10 (3) | 10 (8) | .05 |
| 72 Hours (284 cases and 111 controls) | 14 (5) | 3 (3) | .4 |
| Cumulative incidence (436 cases and 206 controls) | 21 (5) | 22 (11) | .01 |
| eGFR 59-30 mL/min/1.73 m2 | |||
| 24 Hours (118 cases and 103 controls) | 1 (1) | 2 (2) | .6 |
| 48 Hours (105 cases and 80 controls) | 3 (3) | 6 (8) | .2 |
| 72 Hours (95 cases and 76 controls) | 4 (4) | 7 (9) | .2 |
| Cumulative incidence (134 cases and 115 controls) | 6 (5) | 9 (8) | .3 |
| eGFR < 30 mL/min/1.73 m2 | |||
| 24 Hours (5 cases and 21 controls) | 0 | 1 (5) | 1.0 |
| 48 Hours (5 cases and 19 controls) | 1 (20) | 2 (11) | .4 |
| 72 Hours (5 cases and 19 controls) | 1 (20) | 4 (21) | 1.0 |
| Cumulative incidence (5 cases and 22 controls) | 1 (20) | 4 (18) | .9 |
a
Fisher exact test.